TrialThe American journal of psychiatry2021

Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.

Sara Costi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.